$DOCS

Doximity, Inc. (DOCS): Submission of Matters to a Vote of Security Holders

Doximity, Inc. (DOCS) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 27, 2026, Doximity, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on the three proposals outlined in the Co

Original reporting
Published Sep 2, 2026, 8:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$DOCS
Neutral
high confidence
Mentioned
$DOCS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$DOCSNeutralLow
01

Why it matters

The results confirm standard governance actions with no material impact on the company's financials or strategy.

02

Market read

A routine governance filing; unlikely to move the stock.

03

What to watch

The filing does not disclose any proxy battles or changes in board composition beyond the two elected directors.

Relevance 6/10Novelty 2/10Timing: post‑meeting filing

Background

Doximity (DOCS) filed a Form 8‑K detailing the results of its 2026 annual shareholder meeting, including votes on director elections, auditor ratification, and executive compensation.

Company-level read

Ticker impact

$DOCSNeutralHigh confidence
Context

SEC 8‑K reports Doximity's annual shareholder meeting results and vote counts for directors, auditor and compensation.

Expected impact

Minimal impact; price likely unchanged.

Evidence & confidence

Vote results are standard and do not alter financial outlook or operations.

Market effects

None; governance update only.

None; company‑specific filing.

None

Counterpoint

Even routine vote filings can signal shareholder dissent if abstentions rise, but here abstention levels are low.

Key entities

  • Doximity, Inc.

    US‑listed professional networking platform for physicians.

  • Deloitte & Touche LLP

    Independent registered public accounting firm ratified by shareholders.

Related articles

MedAI 8/10

Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance

Doximity's former chief revenue officer, Paul Jorgensen, was ordered to pay $490,000 to the SEC for insider trading. He sold shares based on nonpublic information ahead of negative earnings announcements, avoiding losses and making $2.2 million in profits. Jorgensen was also sentenced to 26 months in prison and ordered to forfeit $2.5 million in a parallel criminal case.

$DOCSMed

Doximity stock falls as Freedom Capital cuts to hold

Doximity Inc (DOCS) shares dropped 5.6% after Freedom Capital downgraded it to Hold, raising its price target to $27. The company beat Q1 estimates, increased full-year revenue guidance, but lowered EBITDA outlook due to AI investment. Freedom Capital noted strong AI search traction but margin concerns and core business softening.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.